Versatile and accomplished Medicinal Chemist with a Ph.D. in Organic Chemistry and a distinguished postdoctoral research background, coupled with over six years of extensive expertise in designing and synthesizing small molecules, specializing in CNS drug discovery through RNA splicing technology. Possessing comprehensive experience in all stages of drug discovery, from hit identification to lead optimization and preclinical development, coupled with a robust understanding of the pharmacokinetic-pharmacodynamic (PK-PD) relationship. An effective collaborator within multidisciplinary teams, seamlessly working with biologists, pharmacologists, legal experts and other professionals to integrate organic chemistry efforts to bring the drug to patients.
Scientist-II (April, 2018—Feb 2020) at PTC Therapeutics, NJ 07080, USA
.svg.png){kind=icon}
Postdoctoral Research (September, 2016—March, 2018) with Prof. Gary A Molander at University of Pennsylvania(UPenn), USA
Accomplishments: